4.8 Review

Periprosthetic joint infection

期刊

LANCET
卷 387, 期 10016, 页码 386-394

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(14)61798-0

关键词

-

资金

  1. Sage Products
  2. DJ Orthopaedics
  3. Janssen
  4. Joint Active Systems
  5. Medtronic
  6. Stryker
  7. TissueGene
  8. Microport
  9. National Institutes of Health (NIAMS)
  10. National Institutes of Health (NICHD)
  11. Tissue Gene
  12. Ongoing Care Solutions
  13. DJO Global
  14. Orthosensor
  15. Siemens AG

向作者/读者索取更多资源

Periprosthetic joint infections are a devastating complication after arthroplasty and are associated with substantial patient morbidity. More than 25% of revisions are attributed to these infections, which are expected to increase. The increased prevalence of obesity, diabetes, and other comorbidities are some of the reasons for this increase. Recognition of the challenge of surgical site infections in general, and periprosthetic joint infections particularly, has prompted implementation of enhanced prevention measures preoperatively (glycaemic control, skin decontamination, decolonisation, etc), intraoperatively (ultraclean operative environment, blood conservation, etc), and postoperatively (refined anticoagulation, improved wound dressings, etc). Additionally, indications for surgical management have been refined. In this Review, we assess risk factors, preventive measures, diagnoses, clinical features, and treatment options for prosthetic joint infection. An international consensus meeting about such infections identified the best practices and further research needs. Orthopaedics could benefit from enhanced preventive, diagnostic, and treatment methods.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据